Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aarti Pharmalabs Limited ( (IN:AARTIPHARM) ) just unveiled an update.
Aarti Pharmalabs Limited, a company involved in the pharmaceutical industry, has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025. This certificate, provided by their Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms the dematerialization status of securities and their listing on stock exchanges. The announcement indicates compliance with regulatory requirements, ensuring transparency and proper record-keeping for stakeholders.
More about Aarti Pharmalabs Limited
Average Trading Volume: 20,499
Technical Sentiment Signal: Buy
Current Market Cap: 75.2B INR
Find detailed analytics on AARTIPHARM stock on TipRanks’ Stock Analysis page.